| Direct Competitor Comparison | |
|---|
| NVO | LLY | PFE | SNY | Industry |
|---|
| Market Cap: | 93.15B | 60.60B | 205.42B | 144.25B | 32.64B |
|---|
| Employees: | 35,154 | 38,350 | 91,500 | 111,974 | 35.15K |
|---|
| Qtrly Rev Growth (yoy): | 0.13 | 0.00 | -0.09 | -0.09 | 1.74 |
|---|
| Revenue (ttm):
| 13.93B | 22.60B | 57.60B | 45.54B | 13.93B |
|---|
| Gross Margin (ttm): | 0.83 | 0.79 | 0.81 | 0.69 | 0.83 |
|---|
| EBITDA (ttm): | 5.78B | 6.51B | 26.80B | 15.16B | 5.72B |
|---|
| Operating Margin (ttm):
| 0.38 | 0.22 | 0.35 | 0.20 | 0.20 |
|---|
| Net Income (ttm): | 3.95B | 4.63B | 10.52B | 5.39B | N/A |
|---|
| EPS (ttm): | 7.21 | 4.16 | 2.09 | 2.03 | 2.00 |
|---|
| P/E (ttm): | 23.86 | 13.43 | 13.86 | 26.86 | 24.04 |
|---|
| PEG (5 yr expected): | N/A | N/A | 4.73 | 2.06 | 1.15 |
|---|
| P/S (ttm): | 6.69 | 2.68 | 3.60 | 3.15 | 3.04 |
|---|
|
| LLY = Eli Lilly and Company | | PFE = Pfizer Inc. | | SNY = Sanofi | | Industry = Drug Manufacturers - Other | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.63 | 0.01 | 79.22B | 17.88 |
|---|
| Genentech, Inc. | Private |
|---|
| Biogen Idec Inc. | BIIB | 226.85 | -0.01 | 53.85B | 36.00 |
|---|
| Genzyme Corporation | Private |
|---|
| Merck Serono S.A. | Private |
|---|
| Gilead Sciences Inc. | GILD | 56.30 | 0.02 | 85.82B | 31.52 |
|---|
| MedImmune, L.L.C. | Private |
|---|
| Life Technologies Corporation | LIFE | 73.54 | 0.00 | 12.65B | 31.13 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.23 | 0.01 | 34.28B | 20.08 |
|---|
| Sandoz International GmbH | Private |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 125.50 | 0.02 | 16.03B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private |
|---|
| Mylan, Inc. | MYL | 31.40 | 0.02 | 11.97B | 20.98 |
|---|
| Pfizer Inc. | PFE | 28.96 | -0.01 | 205.42B | 13.86 |
|---|
| Johnson & Johnson | JNJ | 88.09 | 0.01 | 247.43B | 23.92 |
|---|
| GlaxoSmithKline plc | GSK | 52.22 | 0.00 | 126.48B | 19.09 |
|---|
| Sanofi | SNY | 54.50 | 0.01 | 144.25B | 26.86 |
|---|
| Novartis AG | NVS | 74.15 | -0.01 | 182.20B | 18.82 |
|---|
| Roche Holding AG | RHHBY | 63.13 | -0.01 | 214.26B | 21.13 |
|---|
| AstraZeneca PLC | AZN | 51.56 | -0.01 | 64.45B | 11.40 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.59 | -0.01 | 57.04B | 11.15 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.30 | 0.01 | 71.12B | 49.04 |
|---|
|
| News on Direct Competitors | |
|---|
- PFE
- Final Glance: Pharmaceuticals companies AP Fri 6:03pm
- PFE
- Midday Glance: Pharmaceuticals companies AP Fri 1:33pm
- PFE
- Early Glance: Pharmaceuticals companies AP Fri 10:25am
- SNY
- Presentation Pandemonium Equals 30% Pop at Motley Fool Fri 9:12am
- SNY
- InPlay: Sanofi-Aventis reports positive topline results from pivotal phase III JAKARTA study for JAK2 inhibitor in Myelofibrosis Briefing.com Fri 8:01am
- PFE
- Halozyme rises on pancreatic cancer drug study AP Thu, May 16
- PFE
- Halozyme rises on prostate cancer drug study AP Thu, May 16
- SNY
- Sanofi and Regeneron's Latest Partnership at Motley Fool Thu, May 16
- SNY
- Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month PR Newswire Thu, May 16
- SNY
- The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals Zacks Thu, May 16
- LLY
- Eli Lilly ends development of lymphoma drug AP Fri, May 10
- LLY
- State pharmacy boards back more FDA oversight AP Thu, May 9
- LLY
- Bashful men can buy the little blue pill online AP Mon, May 6
- LLY
- Eli Lilly: CEO Lechleiter will have aorta surgery AP Mon, May 6
- LLY
- Bashful? Buy the little blue pill online AP Mon, May 6
All Headlines for these symbols... Currency in USD. | |
|
0.09%